KLICKSTEIN; Lloyd B.

Patent Applications and Registrations

Patent applications and USPTO patent grants for KLICKSTEIN; Lloyd B..The latest application filed is for "uses of myostatin antagonists, combinations containing them and uses thereof".

Company Profile

3.14.16

KLICKSTEIN; Lloyd B. - Newton MA
Klickstein; Lloyd B - Newton MA
KLICKSTEIN; Lloyd B. - Cambridge MA
Klickstein; Lloyd B. - Brookline MA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Uses Of Myostatin Antagonists, Combinations Containing Them And Uses Thereof App 20220265823 - HATAKEYAMA; Shinji ; et al.	2022-08-25
Uses of myostatin antagonists, combinations containing them and uses thereof Grant 11,357,851 - Hatakeyama , et al. June 14, 2	2022-06-14
Uses Of Myostatin Antagonists, Combinations Containing Them And Uses Thereof App 20200254090 - Kind Code	2020-08-13
Dosage Regimen For The Treatment Of Endometriosis App 20190192485 - PARKIN; Jackie ; et al.	2019-06-27
Azabicyclooctane Derivatives As Fxr Agonists For Use In The Treatment Of Liver And Gastrointestinal Diseases App 20190083473 - Badman; Michael ; et al.	2019-03-21
Compositions And Methods For The Treatment Of Hemoglobinopathies App 20190010495 - BOITANO; Anthony Edward ; et al.	2019-01-10
Pharmaceutical compositions comprising an aromatse inhibitors Grant 10,064,844 - Taylor , et al. September 4, 2	2018-09-04
Antibodies And Methods For Wnt Pathway-related Diseases App 20180066067 - CONG; Feng ; et al.	2018-03-08
Myostatin Or Activin Antagonists For The Treatment Of Sarcopenia App 20170260275 - KORTEBEIN; Patrick ; et al.	2017-09-14
Use of an aromatase inhibitor for the treatment of hypogonadism and related diseases Grant 9,750,724 - Taylor , et al. September 5, 2	2017-09-05
Pharmaceutical Compositions Comprising An Aromatse Inhibitors App 20160346257 - TAYLOR; Ann ; et al.	2016-12-01
Use Of An Aromatase Inhibitor For The Treatment Of Hypogonadism And Related Diseases App 20160243084 - Taylor; Ann ; et al.	2016-08-25
Pharmaceutical compositions comprising an aromatse inhibitors Grant 9,370,505 - Taylor , et al. June 21, 2	2016-06-21
Antibodies and methods for WNT pathway-related diseases Grant 9,296,826 - Cong , et al. March 29, 2	2016-03-29
Use of an aromatase inhibitor for the treatment of hypogonadism and related diseases Grant 9,295,668 - Taylor , et al. March 29, 2	2016-03-29
Antibodies And Methods For Wnt Pathway-related Diseases App 20140328859 - Cong; Feng ; et al.	2014-11-06
Use Of An Aromatase Inhibitor For The Treatment Of Hypogonadism And Related Diseases App 20140309267 - Taylor; Ann ; et al.	2014-10-16
Pharmaceutical Compositions Comprising An Aromatse Inhibitors App 20140213622 - Taylor; Ann ; et al.	2014-07-31
Molecules and Methods for Modulating Complement Component App 20090175875 - ETEMAD-GILBERTSON; Bijan ; et al.	2009-07-09
Human C3b/C4b receptor (CR1) Grant 5,981,481 - Fearon , et al. November 9, 1	1999-11-09
Human C3b/C4b receptor (CR1) Grant 5,856,297 - Fearon , et al. January 5, 1	1999-01-05
Method of treating complement mediated disorders Grant 5,472,939 - Fearon , et al. December 5, 1	1995-12-05
Compositions of soluble complement receptor 1 (CR1) and a thrombolytic agent, and the methods of use thereof Grant 5,256,642 - Fearon , et al. October 26, 1	1993-10-26
Nucleic acids encoding a human C3b/C4b receptor (CR1) Grant 5,212,071 - Fearon , et al. May 18, 1	1993-05-18

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.